MedMAP is designed to save medical device manufacturers time, money and resources in the launch of 510(k) cleared medical devices featuring Agion protection.The market for antimicrobial treated medical devices is rapidly accelerating, driven by the desire to reduce bacterial colonization and biofilm accumulation on surfaces. The benefits of adding the antimicrobial feature have been accepted by the healthcare community including physicians, administrators and purchasing groups due to the proven performance and resulting economic savings.
Accelerating time to market for devices with antimicrobial features is the goal of Scieesent’s MedMAP program.Sciessent’s MedMAP program is designed specifically for medical device manufacturers – including a managed and accelerated FDA 510(k) management program. MedMAP is designed to make the launch of your 510(k) cleared medical device as seamless as possible by saving time, money and resources. Sciessent's team of experts, an extensive catalogue of predicate devices and master device file availability combine to accelerate product development and launch.
For a detailed overview on how Sciessent partners with medical device manufacturers through the development cycle download the Sciessent MedMap Brochure below.